Johns Hopkins ABX Guide
Rimantadine
INDICATIONS
FDA
FDA
- Influenza A
- Treatment for adults ≥17 years
- Prophylaxis: adults and children ≥1 year.
- CDC has not recommended adamantanes for seasonal influenza since 2005–06 because of widespread resistance; high-level resistance persists.[6]
- WHO 2024 did not consider amantadine or rimantadine because of widespread global resistance.[7]
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 6, 2026
Citation
Dzintars, Kathryn, and Paul G Auwaerter. "Rimantadine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/all/Rimantadine.
Dzintars K, Auwaerter PG. Rimantadine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/all/Rimantadine. Accessed September 14, 2026.
Dzintars, K., & Auwaerter, P. G. (2026). Rimantadine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/all/Rimantadine
Dzintars K, Auwaerter PG. Rimantadine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 September 14]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/all/Rimantadine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rimantadine
ID - 540486
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Auwaerter,Paul,M.D.
Y1 - 2026/09/06/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/all/Rimantadine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
